Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience

Oded Shamriz(Hebrew University of Jerusalem), Yuval Tal(Hebrew University of Jerusalem)
Frontiers in Immunology
December 20, 2022
Cited by 10


Related Papers

Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
|The Journal of Allergy and Clinical Immunology In Practice|2017|54